Lycopene ameliorates islet function and down-regulates TLR4/MyD88/NF-κB pathway in diabetic mice and Min6 cells

Yage Liu,Yimiao Tian,Xuan Dai,Tianyuan Liu,Yueyi Zhang,Shan Wang,Hanfen Shi,Jiyuan Yin,Tianshu Xu,Ruyuan Zhu,Yanfei Zhang,Dandan Zhao,Sihua Gao,Xiang-Dong Wang,Lili Wang,Dongwei Zhang

DOI: https://doi.org/10.1039/d3fo00559c

2023-04-28

Abstract:Inflammation of the pancreatic islets triggers β cells dysfunction and type 2 diabetes mellitus (T2DM) onset. While dietary lycopene consumption contributes to protect against T2DM in animal studies, the potential mechanisms of this compound in regulation of islet function in T2DM remain largely unclear. In the present study, by using anti-diabetic metformin as a positive control, we demonstrated that lycopene treatment suppressed islet inflammation and apoptosis in both high-fat diet (HFD)/streptozotocin (STZ)-induced diabetic mice and in Min6 cells exposed to high glucose/palmitic acid (HG/PA)-RAW264.7 conditioned medium. Lycopene intervention resulted in M1/M2 macrophages polarization homeostasis, which are associated with increased insulin secretion, decreased fasting blood glucose levels, and improved lipid profiles in diabetic mice. Furthermore, the protective actions of lycopene were associated with down-regulation of the TLR4/MyD88/NF-κB signaling pathway, which is positively related to inflammation in both diabetic mice and Min6 cells. Collectively, our findings indicated that lycopene ameliorates islet function and apoptosis and attenuates hyperglycemia and dyslipidemia, via the regulation of TLR4/MyD88/NF-κB signaling pathway. This study highlights dietary lycopene consumption as a novel strategy for the management of patients with diabetes.

biochemistry & molecular biology,food science & technology